10 Best Get Rich Quick Stocks to Buy Right Now
At a time when many investors are seeking life-changing opportunities, stocks capable of generating outsized returns continue to attract significant interest.
Eyepoint Inc. (EYPT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RWC Asset Management Tord Stallvik (Ceo) | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.15 | 1,500 | $19,723.80 | 100,665 | 2026-03-16 | Filing | |
| $5.99 | 5,000 | $29,950.00 | 36,500 | 2025-05-19 | Filing | |
| $5.81 | 5,000 | $29,050.00 | 31,500 | 2025-05-16 | Filing | |
| $5.47 | 5,000 | $27,350.00 | 26,500 | 2025-05-15 | Filing | |
| $5.42 | 5,000 | $27,100.00 | 21,500 | 2025-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.02 | 2,438 | $36,611.93 | 0 | 2026-06-30 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 2,438 | 2026-06-30 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-04-17 | Filing | |
| $17.87 | 2,438 | $43,571.69 | 0 | 2026-03-04 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-02-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 400,044 | $5,720,629 | 0.08% | |
| 2. | 68,465 | $979,049 | 0.08% | |
| 3. | 51,190 | $732,017 | 0.01% | |
| 4. | 50,000 | $705,500 | 0.01% | |
| 5. | 45,700 | $644,827 | 0.02% |
News See All
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript May 6, 2026EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2025 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2025 Earnings Call Transcript March 4, 2026EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2025 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2025 Earnings Call Transcript November 5, 2025EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2025 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2025 Earnings Call Transcript August 6, 2025EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2025 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2025 Earnings Call Transcript May 7, 2025EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript March 5, 2025EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript
Operator: Good morning. My name is Kevin and I will be your conference operator today.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Leeway and I will be your conference operator today.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2023 Earnings Call Transcript
Operator: Good morning. My name is [indiscernible] and I will be your conference operator today.
Hedge Fund Resource Center